Your Partner for Growth, Hybridan

Hybridan

Your Partner for Growth

Our passion is raising growth capital for exciting, fast growth companies that want to take their business to the next level. We raise capital for companies both listed and unlisted in the most efficient manner possible and pride ourselves as being one of the few consistently profitable broking firms in the City. This has been achieved through a highly disciplined approach when seeking to create both corporate and institutional relationships.

Equity Bottom-Up

<ul>
<li>1 May: Lansdowne Oil &amp; Gas (AIM: LOGP), the Company currently suspended from trading on AIM, announced the conditional acquisition of Sao Gabriel Mineracao Ltda. a graphite project in Brazil whilst continuing to progress its litigation claim under the Energy Charter Treaty which has now received litigation funding to pursue a minimum of US$100m (plus interest) claim against Ireland in relation to the Barryroe project.</li>
<li>The Company has published its AIM Admission Document and has conditionally completed an equity fundraising of £1.9m by way of a placing.</li>
<li>Net proceeds of the Fundraising will allow for the advancement of Macaubas Project through an active exploration programme and provide general working capital. </li>
</ul>


1 May: Lansdowne Oil &amp; Gas (AIM: LOGP), the Company currently suspended from trading on AIM, announced the conditional acquisition of Sao Gabriel Mineracao Ltda. a graphite project in Brazil whilst continuing to progress its litigation claim under the Energy Charter Treaty which has now received litigation funding to pursue a minimum of US$100m (plus interest) claim against Ireland in relation to the Barryroe project.
The Company has published its AIM Admission Document and has conditionally completed an equity fundraising of £1.9m by way of a placing.
Net proceeds of the Fundraising will allow for the advancement of Macaubas Project through an active exploration programme and provide general working capital. 


United Kingdom

Abingdon Health is an international developer, manufacturer, and distributor of lateral flow assay diagnostic tests, also known as rapid tests. The company provides comprehensive contract development and manufacturing (CDMO) services for rapid diagnostics across various sectors, including healthcare, animal health, and environmental testing. Abingdon Health is headquartered in York, England, and was founded in 2008.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Abingdon Health (ABDX LN)

Hybridan Small Cap Feast: 6 May 2026

Net proceeds of the Fundraising will allow for the advancement of Macaubas Project through an active exploration programme and provide general...

Hybridan

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)